Albemarle Corporation (ALB)

In the past six months, Albemarle's stock experienced notable movements. As of March 26, 2026, ALB stock was up 130.45% over the past 12 months but down 6.60% over the past 30 days. On January 7, 2026, the stock rose 2.5% following an upgrade by Baird. In February 2026, Albemarle reported its fourth-quarter and full-year 2025 results with increased net sales but a net loss. Albemarle decided to idle the Kemerton lithium hydroxide plant and amended its credit facility. The company initiated an environmental review for a lithium project in Chile and upsized its debt tender offer. KPS Capital Partners, LP completed the acquisition of a stake in Ketjen Corporation. Michelle T. Collins and Mark R. Widmar were appointed to the Board of Directors. A quarterly common stock dividend was announced. The stock price has moved in tandem with lithium prices.

Demand for Albemarle's key products, particularly lithium, is driven by long-term trends rather than significant seasonality. Global lithium demand is projected to surge, primarily fueled by the adoption of electric vehicles and energy storage solutions. Demand for bromine is also expected to grow. The underlying demand for its products is characterized by strong, sustained growth rather than distinct seasonal patterns.

Albemarle Corporation is a global specialty chemicals company founded in 1993, operating in the Basic Materials sector. It develops, manufactures, and markets specialty chemicals like lithium, bromine, and catalysts for industries such as energy storage, automotive, and pharmaceuticals. The company operates through three segments: Energy Storage, Specialties, and Ketjen.

Albemarle has a significant global presence with operations in 34 locations across five continents, including the Americas, Asia, Europe, and the Middle East. Key operational areas include lithium brine resources in Chile and the United States, hard-rock lithium operations in Australia, and conversion and refining plants in North America, Australia, Chile, and China. It also has bromine production plants in multiple countries and a bromine joint venture in Jordan.

Albemarle maintains a strong reputation as a global leader in specialty chemicals, particularly in lithium and bromine solutions. The company has been recognized on Forbes lists. While the stock price has seen volatility, there haven't been specific major events that have significantly damaged Albemarle's overall brand reputation beyond market-related fluctuations.

Albemarle Corporation's ownership is primarily composed of institutional investors, holding approximately 83.86% of the stock, while insiders hold about 0.29%. Major institutional shareholders include Vanguard Group Inc., Capital World Investors, and BlackRock, Inc.